William Blair & Company’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-16,599
| Closed | -$38K | – | 1909 |
|
|
2021
Q4 | $38K | Sell |
16,599
-6,306
| -28% | -$14.4K | ﹤0.01% | 1798 |
|
|
2021
Q3 | $66K | Sell |
22,905
-4,058
| -15% | -$11.7K | ﹤0.01% | 1655 |
|
|
2021
Q2 | $102K | Hold |
26,963
| – | – | ﹤0.01% | 1610 |
|
|
2021
Q1 | $91K | Buy |
26,963
+1,411
| +6% | +$4.76K | ﹤0.01% | 1605 |
|
|
2020
Q4 | $72K | Sell |
25,552
-47,250
| -65% | -$133K | ﹤0.01% | 1581 |
|
|
2020
Q3 | $183K | Buy |
72,802
+9,252
| +15% | +$23.3K | ﹤0.01% | 1332 |
|
|
2020
Q2 | $863K | Sell |
63,550
-1,243
| -2% | -$16.9K | ﹤0.01% | 758 |
|
|
2020
Q1 | $491K | Hold |
64,793
| – | – | ﹤0.01% | 873 |
|
|
2019
Q4 | $409K | Sell |
64,793
-8,608
| -12% | -$54.3K | ﹤0.01% | 1063 |
|
|
2019
Q3 | $288K | Sell |
73,401
-2,000
| -3% | -$7.85K | ﹤0.01% | 1133 |
|
|
2019
Q2 | $365K | Hold |
75,401
| – | – | ﹤0.01% | 1087 |
|
|
2019
Q1 | $618K | Buy |
75,401
+5,826
| +8% | +$47.8K | ﹤0.01% | 895 |
|
|
2018
Q4 | $385K | Buy |
+69,575
| New | +$385K | ﹤0.01% | 993 |
|